STAT3 and breast cancer: In addition, a high level of serum resistin has been reported to be correlated with poor overall survival of patients with breast cancer, which is caused by the activation of Toll-like receptor 4 (TLR4)/NF-κB/STAT3 signaling pathway [47,48].